BD Phoenix diagnostic panel misformulated minocycline causes false resistance reporting
BD Phoenix PMIC/ID-107 diagnostic panels contain misformulated minocycline that may produce false antibiotic resistance results, potentially delaying appropriate patient treatment.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving diagnostic error that could delay appropriate antibiotic treatment. Per the rubric, this is a risk-of-harm product where patient injury has not yet been reported, scoring High (3).
Plain-English summary
BD Becton Dickinson has recalled BD Phoenix PMIC/ID-107 diagnostic panels (Lot 1355046, expiration 31 January 2023) due to misformulation of minocycline in the test panels. Approximately 13,900 units were distributed nationwide in the United States.
The panels are used in clinical laboratories to rapidly identify bacteria and perform antimicrobial susceptibility testing. The misformulated minocycline causes the panel to report false resistance to minocycline, even when bacteria are susceptible to the drug. If a laboratory's quality control testing of the batch passes, the false results may go undetected and be reported to clinicians.
False resistance reporting could delay or prevent appropriate treatment with minocycline. Healthcare facilities and clinical laboratories that received affected units should immediately discontinue use of the affected lot and contact BD for instructions on appropriate corrective actions.
The recalled product
- Product
- BD Phoenix PMIC/ID-107: The Phoenix PMIC/ID panel is used for the rapid identification and susceptibility of most aerobic and facultative anaerobic gram-positive bacteria of human origin with selected antimicrobial agents when used with the BD Phoenix Automated Microbiology Syst
- Manufacturer
- Becton Dickinson & Co.
- Hazard
- diagnostic-error
- false-resistance-reporting
- minocycline-misformulation
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Trays Recalled Due to Quality and Efficacy Concerns
FDA (Devices) · 2026-06-03
- HighMedline Medical Convenience Kit Recalled: Wrong Syringe Type Inside
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03